Mammogram Mail- and Phone-based Interventions

NCT ID: NCT05853848

Last Updated: 2024-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

14386 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-10

Study Completion Date

2024-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The project aims to evaluate four different versions and modalities of interventions encouraging mammogram screening among all eligible women due or overdue for screening. The evaluation will compare among the following forms of outreach to help determine whether (a) live calls are more effective at increasing mammogram screening than other forms of outreach and (b) each form of outreach is more effective than no outreach: (1) a postcard, (2) a letter, (3) an auto-dialer phone message, and (4) a live call from a care gaps team. The interventions will be rolled out over many months, allowing for comparisons of effectiveness against those who have not yet been contacted.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Each intervention will be rolled out to only a subset of the total population each month, such that all patients will receive one of the interventions over the course of 7 months. Active arms will be compared contemporaneously against a passive control group consisting of active arm participants for whom the intervention has not yet begun, as well as a random subset of participants who are excluded before the future intervention begins.
Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard postcard

Patients in this arm will receive a postcard with words and an image, typical of outreach in prior years, encouraging them to schedule their annual mammograms.

Group Type ACTIVE_COMPARATOR

Postcard

Intervention Type BEHAVIORAL

Postcard with phone number to call for help scheduling a mammogram.

Formal letter

Patients in this arm will receive a letter from the Geisinger Health Plan (on Geisinger letterhead) noting that they're overdue for a mammogram and encouraging them to schedule.

Group Type EXPERIMENTAL

Letter

Intervention Type BEHAVIORAL

Letter with phone number to call for help scheduling a mammogram.

Auto-dialer

Patients in this arm will receive a call from an auto-dialer with a message noting that they're overdue for a mammogram and encouraging them to schedule.

Group Type EXPERIMENTAL

Auto-dialer

Intervention Type BEHAVIORAL

Auto-dialer with option to press button for help scheduling a mammogram.

Live call

Patients in this arm will receive a call from a Geisinger Health Plan representative noting that they're overdue for a mammogram and encouraging them to schedule (and helping them schedule if they are interested).

Group Type EXPERIMENTAL

Live call

Intervention Type BEHAVIORAL

Live call offering help scheduling a mammogram.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Postcard

Postcard with phone number to call for help scheduling a mammogram.

Intervention Type BEHAVIORAL

Letter

Letter with phone number to call for help scheduling a mammogram.

Intervention Type BEHAVIORAL

Auto-dialer

Auto-dialer with option to press button for help scheduling a mammogram.

Intervention Type BEHAVIORAL

Live call

Live call offering help scheduling a mammogram.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female Geisinger Health Plan members between ages 52 and 74 as of December 31, 2023
* Overdue for annual mammogram
* Continuously enrolled with the Geisinger Health Plan as of October 1, 2021
* Can be contacted via both phone and mail

Exclusion Criteria

* Geisinger Health Plan members on a do-not-contact list
* Had a mammogram as of October 1, 2021
* In hospice, using hospice services, or receiving palliative care as of January 1, 2023
* Medicare members 66 years of age or above at time of outreach, who are institutionalized or have both frailty and advanced illness
* Had a bilateral mastectomy at any time
Minimum Eligible Age

51 Years

Maximum Eligible Age

74 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Geisinger Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amir Goren

Program Director, Behavioral Insights Team

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amir Goren, PhD

Role: PRINCIPAL_INVESTIGATOR

Geisinger Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Geisinger

Danville, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-0369

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Personalized Breast Cancer Screening
NCT06060938 ACTIVE_NOT_RECRUITING NA
Genetic Education in BRCA Families
NCT03544983 ENROLLING_BY_INVITATION NA